Related by context. All words. (Click for frequent words.) 73 Distribution Agreement 69 License Agreement 69 Licensing Agreement 69 Supply Agreements 67 Agreement 66 Collaboration Agreement 65 Purchase Agreement 63 Teaming Agreement 63 Agreements 63 Lease Agreement 61 Joint Venture Agreement 61 Licence Agreement 60 Purchase Agreements 59 Patent License Agreement 59 Reseller Agreement 59 Distributor Agreement 58 Exclusivity Agreement 58 Commercialization Agreement 58 Distribution Agreements 58 Acquisition Agreement 58 Polysilicon Supply Agreement 57 Offtake Agreement 56 Loan Agreement 56 Distributorship Agreement 56 Transfer Agreement 56 Exclusive Distribution 56 Cooperation Agreement 55 Wafer Supply 55 Asset Purchase Agreement 55 Termination Agreement 55 Strategic Alliance 55 Securities Purchase Agreement 55 Definitive Agreements 55 License Pact 55 Contract 54 License Option Agreement 54 Definitive Merger Agreement 54 agreement 54 Sublicense Agreement 54 Stock Purchase Agreement 54 Settlement Agreement 54 Inks Agreement 54 Exclusive License Agreement 53 Commitment Letter 53 Joint Venture 53 Forms Joint Venture 53 Subsidiary Enters 53 Sponsorship Agreement 53 Confidentiality Agreement 53 Definitive Agreement 53 Signs Agreements 53 Framework Agreement 53 LOI 53 definitive agreements 52 Financing Agreements 52 Share Purchase Agreement 52 MOU 52 Binding Agreement 52 License Agreements 52 agreements 52 Affiliation Agreement 52 Enters Agreement 52 Option Agreement 52 Power Purchase Agreement 52 Amended Agreement 52 Interconnection Agreement 52 Cross License Agreement 52 Assignment Agreement 52 Distribution Pact 52 Forbearance Agreement 52 Signs Licensing Agreement 52 Waiver Agreement 51 Participation Agreement 51 definitive agreement 51 Joint Venture Agreements 51 Licensing Deal 51 Exclusive Licensing Agreement 51 Cooperation Agreements 51 Representation Agreement 51 Signs Joint Venture 51 Partnership Agreement 50 Inks Supply 50 Cross Licensing Agreement 50 Enters Into 50 Term Sheet 50 Formal Agreement 50 Licensing Pact 50 Signs MOU 50 Signs Agreement 50 Standstill Agreement 50 Secures Patent 50 Enters Into Agreement 50 Formal Agreements 50 Enters Into Joint Venture 50 Joint Venture JV 50 Subsidiary Signs 50 Agreement SEDA 50 Enters Into Strategic 50 Establish Joint Venture 50 Announces License Agreement 50 Contracts 49 Purchase Option Agreement 49 Signs License Agreement 49 Reaches Agreement 49 Signs Binding 49 Exclusive License 49 Misonix Announces 49 Value Added Reseller Agreement 49 Arrangement MFA 49 Announce Licensing 49 Property Option Agreement 49 Development Agreement CRADA 49 Pact 49 CRADA 49 Purchase Order 49 Master License Agreement 49 Announces Definitive Agreement 49 Signs Long Term 49 Merger Agreement 49 Obtains License 49 Option Agreements 49 Amalgamation Agreement 48 Leases 48 Secures Contract 48 Contribution Agreement 48 Subsidiary 48 Signs Option Agreement 48 EPC Contract 48 Worldwide Licensing Agreement 48 Definitive Purchase Agreement 48 binding Letter 48 LoI 48 Licensing Agreements 48 Implementation Agreement 48 Letter Agreement 48 Tripartite Agreement 48 Enters Strategic 48 Enters Into Long Term 48 Subscription Agreement 48 Enters Joint Venture 48 Signs Memorandum 48 LDK Solar Signs 48 Executes Agreement 48 Inks Licensing Deal 48 Receives Commitment 48 Secures Long Term 48 Amending Agreement 48 Formal Option Agreement 48 Enters Into Letter 48 Outsourcing Contract 47 Enters Into Licensing Agreement 47 agreementwith 47 Enters Into Definitive Agreement 47 Subsidiary Enters Into 47 Steelworkers Ratify 47 Files Patent Application 47 Cooperation Framework Agreement 47 Contract Renewal 47 Photovoltaic Module 47 Consent Agreement 47 Submits Application 47 Sign License Agreement 47 Lease Agreements 47 Jacada Signs 47 Receives Approval 47 Concession Agreement 47 Distributorship 47 Farmout Agreement 47 Milestone Payments 47 License Application 47 Receives Confirmation 47 Escrow Agreement 47 Terminates Contract 47 Signs Contract 47 Signs Pact 47 Obtains Approval 47 Signs Definitive Agreement 47 Patent Issued 47 Enters Into Definitive 47 Settle Litigation 47 Acacia Subsidiary Enters 47 Signs Definitive 47 Awarded Multi 47 Inks Pact 47 Framework Agreements 46 Closes Merger 46 Transfer Agreements 46 Million Dollar Contract 46 Awarded Contracts 46 Announce Joint Venture 46 Renews Agreement 46 MoU 46 Receives Patent 46 Entered Into 46 Enters Into Exclusive 46 Finalizes Agreement 46 Inks MOU 46 Inks Multi 46 Offtake 46 Settlement Agreement Regarding 46 Completes Transaction 46 HSR Waiting Period 46 intent LOI 46 Acquire Assets 46 Terminates Agreement 46 Mutually Agree 46 Sign Licensing Agreement 46 Revolving Credit Agreement 46 Renews Multi 46 Combination Agreement 46 Enter Into Definitive 46 Commercialize 46 Agreement HoA 46 Enter Into 46 Settles Litigation 46 Signs LOI 46 Patent Covering 46 Extends Collaboration 46 Exclusive Distributorship 46 Consent Decree 46 PV Module 46 GSPAs 46 Announces Licensing Agreement 46 Signs Licensing 46 joint venture 46 exclusive distributorship 46 Non Binding Letter 46 Sign Definitive Agreement 46 Secures Financing 45 Signs MoU 45 HoA 45 Signs Multi 45 Enters Into License Agreement 45 Announces Termination 45 Subsidiary Receives 45 Secured Facility 45 Completes Asset 45 Solar Wafer 45 Joint Venture Agreement JVA 45 Asset Purchase Agreements 45 Announces Definitive Merger 45 Workers Reach Tentative 45 Confidentiality Agreements 45 Recapitalization Agreement 45 Licence Agreements 45 Intergovernmental Agreement 45 Electricity Purchase Agreement 45 Finalizes Contract 45 Seeks Approval 45 TOP Ships Announces 45 licensing agreements 45 Acquires Exclusive 45 Signs Non Binding 45 Tolling Agreement 45 Completes Merger 45 Completes Reverse Merger 45 Announces FDA Clearance 45 Early Termination 45 Expands Distribution 45 Final Approval 45 Enters Into Collaboration 45 Agree ment 45 Enters Negotiations 45 Clinical Trials Agreement 45 PDS PDS 45 Amends Agreement 45 Strategic Partnership 45 Exclusivity 45 Patents Covering 45 Begins Shipment 45 Signs LoI 45 Inks LOI 45 Milestone Payment 45 wholly owned subsidiary 45 Dendritic Nanotechnologies Inc. 45 Acquire Majority 45 Disposition Agreement 45 anagreement 45 Securities Purchase Agreements 45 Completes Acquisitions 45 farmin agreement 45 Jointly Develop 45 Memorandum 45 Terminates Merger Agreement 45 Agreement Reached 45 Receives Approval From 45 Option Deed 45 Expands Scope 45 Merger Transaction 45 Restated Agreement 45 Signs Letter 45 farmout agreement 45 Achieves Significant 44 Wins Approval 44 FY# Loss Widens 44 Members Ratify 44 Receives FDA Clearance 44 Stockholders Approve Merger 44 Inks Joint Venture 44 Signs Binding Letter 44 Receives Authorization 44 Committed Equity 44 Pacts 44 #.#.# Meldung [001] 44 Signs Merger Agreement 44 Intent LOI 44 Announces Tentative Agreement 44 HHSN#C 44 Inks Distribution 44 Reaches Pact 44 Derma Sciences Announces 44 Announces Successful Completion 44 Formalizes 44 Exclusive Licensing 44 Signs Distribution 44 Receives Notification 44 Receives Permit 44 Lease Renewal 44 Binding Letter 44 Completes Purchase 44 Finalises 44 Active Pharmaceutical Ingredient 44 Confirms Commitment 44 Receives Approvals 44 Complies 44 No. HHSN#C 44 Extends Tender Offer 44 Complete Merger 44 Credit Agreement 44 Emission Reductions 44 Safic Alcan 44 Teijin Pharma 44 Gets Approval 44 Contract Extension 44 Definitive Acquisition 44 Contracts Totaling 44 Miraculins Announces 44 Exclusive Distributor Agreement 44 Negotiates 44 Procures 44 Subscription Agreements 44 Pilots Ratify 44 Establishes Joint Venture 44 Million Pounds Sterling 44 Obtains Patent 44 Subsidiary Acquires 44 contractual agreements 44 Injection Molded 44 Successful Completion 44 Reaches Tentative 44 Announce License Agreement 44 Jointly Announce 44 Finalize Joint Venture 44 Permanent Injunction 44 FDA Clears 44 GPSi Asia 44 agreemen 44 Current Merger Agreement 44 Farmout 44 STERIS Corporation Announces 44 Announce Licensing Agreement 44 Genpharm 44 Inc. OTCBB BOCL 44 Patent Licensing Agreement 44 Patent Dispute 44 Finalizes Acquisition 44 Arbitration Proceeding 44 Workers Ratify 44 Signs Deal 44 Biomarker Study 44 wholly ownedsubsidiary 44 Has Entered Into 44 Signs Framework Agreement 44 Multimillion Dollar Contract 44 Strategic Relationship 44 Material Transfer 44 Reacquires 44 Strengthens Balance Sheet 44 Promissory Note 44 Stipulated 44 Workers Approve 44 Signs Multiyear 44 InvaGen 43 Closes Financing 43 Renegotiates 43 Signs Lease 43 Closes Previously Announced 43 FDA Clearance 43 Implementation Deed 43 creditworthy shippers 43 Signs Exclusive 43 Pending Litigation 43 Subsidiary Wins 43 SES ASTRA Signs 43 Exclusivity Period 43 Tenancy Agreement 43 Purchase Agreement dated 43 Further Validates 43 Resolves Dispute 43 Develops Novel 43 Sublicense 43 Inks Contract 43 Signs Purchase Agreement 43 Wins Contract 43 Stock Repurchase Plan 43 Gets FDA Clearance 43 Completes Transition 43 Settles Patent Litigation 43 Obtains 43 Order Approving 43 Equipment Deals 43 Patent Portfolio 43 DIP Loan 43 Milestone Achieved 43 Ongoing Connected Transactions 43 Shareholders Approve Merger 43 Patent Infringement Case 43 theagreement 43 Reach Agreement 43 Hyperion Catalysis International 43 Board Authorizes 43 Completes Financing 43 Order Bookings 43 Acquires Remaining Interest 43 Successfully Tests 43 Announces Signing 43 Amended Option Agreement 43 Acquires Assets 43 Agreement JOA 43 tripartite MoU 43 Enters Exclusive 43 Announce Definitive Agreement 43 Clearford Announces 43 Receives Notice 43 Employees Ratify 43 Extend Collaboration 43 Settlement Agreements 43 Purchase Agreement SPA 43 Exercises Option 43 Settlement Reached 43 Standby Equity Distribution 43 Completes Patient Enrollment 43 Binding Offer 43 OTCBB APCSF 43 Receives Order 43 Expands Relationship 43 Inks License 43 Underwriting Agreement 43 Solar Modules 43 Finalizes 43 GRAS Status 43 Subsidiary Completes 43 Sign Definitive Merger 43 Synerx 43 Files IND 43 Plea Agreement 43 Workers Reject 43 Expand Relationship 43 Closes Acquisition 43 Trademark License Agreement 43 Resource Adequacy 43 Announces Consummation 43 Inks Long Term 43 Therapeutic Competitors Report 43 Discontinues 43 Strengthens Position 43 Ink Pact 43 Enters Into Negotiations 43 Receives Milestone Payment 43 Polysilicon Production 43 Reaches Settlement Agreement 43 Terminates Letter 43 Commence Production 43 FDA Approves 43 Acquire Controlling Interest 43 Loan Facility 43 Levucell 43 Discontinuance 43 PROCAPS 43 Completes Merger With 43 Agreement CPA 43 Regains Nasdaq 43 Ink Deal 43 Technip Awarded 43 MOUs 43 Announces Refinancing 43 GMP Certificate 43 Initiates Enrollment 43 Terminates 43 binding LOI 43 Inks Exclusive 43 Amend Merger Agreement 43 Acquires Controlling Interest 43 Roaming Agreement 43 Extends Relationship 42 Medicure Announces 42 Enters Into Distribution 42 Enters Into Settlement Agreement 42 Announces Tentative Approval 42 Previously Announced 42 Commercializes 42 Reduces Debt 42 Osiris retains 42 Articulation Agreement 42 Asset Swap 42 Definitive Option Agreement 42 Enters Into Partnership 42 Forbearance Agreements 42 WebTech Wireless Announces 42 Successfully Integrates 42 BioSyent Pharma 42 Completes Purchase Of 42 Franchise Agreements 42 Announce Receipt 42 Awarded Contract 42 Regains Full 42 Loramyc ™ 42 Executes Letter 42 Commences Operations 42 Announce Successful Completion 42 Expand Collaboration 42 Proposed Amalgamation 42 Announce Agreement 42 Distributor 42 Expands Capacity 42 Extend Relationship 42 GCL Silicon Technology 42 Expanded Indication 42 Thin Film Solar Modules 42 Patent Upheld 42 subsidiary 42 Credit Facility 42 NMP# ® 42 Flamel Technologies Announces 42 Important Milestone 42 Datang Renewable Power 42 Pooling Agreement 42 Receives CE Marking 42 Tenancy Agreements 42 Proposed Merger 42 Laser Welding 42 sublicense 42 Material Definitive Agreement 42 PUC Approves 42 Completes Acquisition 42 Contract Modification 42 Gets Clearance 42 Completes Private Placement 42 Submits IND 42 Manufacturer Selects 42 Wholly Owned Subsidiary 42 agrement 42 Announces Organizational Changes 42 commercialize telaprevir 42 Retains CCG Investor Relations 42 Taglich Brothers Initiates Coverage 42 Qualification Testing 42 Successfully Demonstrates 42 Preferred Stock Purchase Agreement 42 Successfully Completes 42 Announces Voluntary Recall 42 Supplier 42 Files Shelf Registration Statement 42 Contract MILC program 42 Subcontract 42 Receives Favorable Ruling 42 FTG Announces 42 Announces Proposed Acquisition 42 FDA Okays 42 Performance Incentive Plan 42 WinRho R SDF 42 Subsidiary Agrees 42 Oral Calcitonin 42 Expand Capacity 42 Asset Sale 42 contract 42 OMJPI 42 Complies With 42 Credit Facilities 42 NQCI 42 Handok Pharmaceuticals 42 Terminate Agreement 42 BioElectronics Corporation Announces 42 Collaborates 42 Initiates Clinical 42 Establishes Strategic 42 joint venture JV 42 Forms Strategic 42 Completes Successful 42 irrevocable undertakings 42 TVI Subscription Agreement 42 Requisite Consents 42 Bioniche Teoranta 42 Announces Successful 42 Settles Patent Suit 42 Headwaters Incorporated Announces 42 JHP Pharmaceuticals LLC 42 commercialize Dimebon 42 Flexpoint Announces 42 Shenyang Brilliance Power 42 Intractable Hiccups 42 Forbearance Period 42 Completes Previously Announced 42 Announce Merger Agreement 42 Named Exclusive Distributor 42 Research Organisations CROs 42 Tri Brid Engine Electric/Flex-Fuels/H2O 42 Acquires Controlling Stake 42 Senior Secured Credit 42 Safeguards Agreement 42 Pinnacle Digest Looking 42 Increases Ownership 42 Repurchase Agreement 42 Recall Issued 42 Completes Reorganization 42 Nippon Kayaku 42 Announces Definitive Agreements 42 DOE USEC 42 Patent Infringement Suit 42 Completes Tender Offer 42 Subsidiary Expands 42 Expiration Dates 42 Receives Tentative FDA 42 Tanabe Seiyaku 42 Daiichi Suntory Pharma 42 Acquisition Proposal 42 Receives Favorable 42 offtake agreements 42 BioSante Pharmaceuticals Announces 42 Inks Licensing Agreement 42 Expands Portfolio 42 Monetizes 42 Seeks Bids 41 Finalizes Joint Venture 41 Announce Exclusive 41 FY# Loss Narrows 41 MOU memorandum 41 Nasdaq Listing Requirements 41 Clears Path 41 WiNet System 41 Xing Yang Security 41 CCI Pellet Agreements 41 Concludes Acquisition 41 Enhances Capabilities 41 CollaRx GENTAMICIN SURGICAL IMPLANT 41 Study Validates 41 Original Equipment Manufacturer OEM 41 Doubles Capacity 41 Establishes Subsidiary 41 Announce Commencement 41 Announces Shareholder Approval 41 Acquire Controlling Stake 41 Annette Bening Tom Hanks 41 PROTONIX 41 Announces Debt Settlement 41 Terminate Merger 41 Receives Initial 41 Testosterone Gel 41 Completes Installation 41 ARRIS Announces 41 fifty fifty joint venture 41 Farmin Agreement 41 Term Loan Facility 41 Enrolls First 41 Torii Pharmaceutical 41 Color Additives 41 Awarded GSA Schedule 41 Contracts Awarded 41 Pregnancy MTP Act 41 Announces Issuance 41 Extends Offer 41 Partners Invests 41 Negotiations Continue 41 Urocidin TM 41 Presents Positive Preclinical 41 subsidiary Biovail Laboratories 41 Forges Partnership 41 Strengthens Its 41 Convertible Promissory Note 41 Subsidiary Awarded 41 Biodegradable Plastic 41 Reorganization Plan 41 Announces Divestiture 41 Entrusts 41 Receives SFDA Approval 41 Closes Sale 41 supplemental indentures effecting 41 Bao Tai 41 Settle Patent Dispute 41 Announce Expiration 41 Awarded Patent 41 Offset Obligation 41 Stipulation 41 Enters Definitive Agreement 41 Announce Collaboration 41 Consent Judgment 41 Gene Expression Analysis 41 Nutra Pharma Announces 41 Final Stages 41 exclusive sublicense 41 TSX VENTURE APH 41 Shareholders Approve Proposed 41 GEHC 41 contractual arrangements 41 Secured Promissory Note 41 Begins Shipping 41 Receives Stockholder Approval 41 Granted Orphan Drug 41 Receives Contract 41 Taiho Pharmaceutical 41 Announces Recapitalization 41 Enters Into Multi 41 Initiates Phase II 41 Awarded Contract Extension 41 Crowflight Announces 41 Completes Divestiture 41 Patents Issued 41 Zcom Networks Announces 41 USOTC SSWC 41 Announce Settlement 41 Commences Subsequent 41 Option Agreement whereby 41 Wind Turbine Components 41 Unsolicited Tender Offer 41 DIP financing facility 41 Expanding Presence 41 Successfully Concludes 41 Sole Source 41 Extend Partnership 41 Executes Definitive Agreement 41 Financing Facility CEFF 41 Announces Initiation 41 UAW Reach Tentative 41 Completes Refinancing 41 Million Financing 41 Mondo Minerals 41 Ratifies 41 Long Term Relationship 41 bareboat employment 41 Acquire Privately Held 41 restated revolving 41 Licenses Patents 41 Achieves Milestone 41 Acquires Majority Stake 41 Signs Definitive Agreements 41 Obtains Exclusive Rights 41 Secures Exclusive 41 definitive documentation 41 Initiates Clinical Trials 41 Inks Deal 41 Increases Capacity 41 Achieves ISO #:# Certification [002] 41 Agreement LSA 41 mutually satisfactory definitive 41 Submits Response 41 Exclusive Licensee 41 Obtains Financing 41 SpeBio joint venture 41 Submits NDA 41 Patent Infringement Litigation 41 JXTC 41 ZTEST Announces 41 GEO Monitor IPO Newsflash 41 Initiates Voluntary Recall 41 Output Drops 41 Reaches Definitive Agreement 41 Consummates 41 Forges Ahead 41 engines stampings 41 Partnering Agreements 41 Corporation OTCBB YASH 41 Decision Imminent 41 Frbiz Analyzes 41 SulphCo Announces 41 Concession Agreements 41 Marks Milestone 41 Refinances Debt 41 FEED Contract 41 Fulun Steel 41 Has Entered 41 GSA SmartBUY 41 Holdings HKSE # 41 Presents Positive 41 Successfully Implemented 41 FDA Accepts 41 Director Shareholding 41 Second Tranche 41 Schweitzer Mauduit Announces 41 Affreightment 41 Serica Energy plc Serica 41 Develop Novel 41 forbearance agreement 41 CKGT 41 Closes Acquisition Of 41 Highly Concentrated 41 Senior Secured Term 41 NYSE Amex Listing 41 Anti CD# Antibody 41 Resolve Dispute 41 OPGX 41 Commences Cash 41 Nanophase Announces 41 Extends Contract 41 Brake Pads 41 Completes Expansion 41 Subsidiary Awarded Contract 41 Global FranTech 41 Methylphenidate Transdermal System 41 Enters Into LOI 41 Initiates Clinical Trial 41 Acquire Majority Stake 41 Evonik Degussa GmbH 41 Revolving Credit 41 Fluor Awarded 41 LaBarge Awarded 41 Completes Enrollment 41 MAIN FACTS 41 Underwriters Exercise 41 Packaging Materials 41 Contract Analyst Blog 41 Modification Agreement 41 Jointly Explore 41 Receives Clearance 41 Agreements FTA 41 Million Contract 41 Revolving Credit Facility 41 Awarded GSA 41 Use Thereof 40 Receives Orphan Drug Designation 40 Jilin Refinery 40 Discharge Permit 40 EN NEO 40 secured promissory note 40 Receives Tentative Approval 40 Forges Strategic 40 Rotarix R 40 MBMI Closes 40 mutually terminated 40 Agreements FTAs 40 Manufacturing Facility 40 Execute Definitive 40 ESTRASORB R 40 Engine Oxygenator 40 Secured Revolving Credit 40 Develop Next Generation 40 Pending Acquisition 40 supplemental indentures 40 Explores Strategic Alternatives 40 DIP Financing Facility 40 Tentative Agreement 40 contractual 40 Secures Funding 40 Private Placement Offering 40 Conditional Approval 40 Second Amended 40 trust indenture 40 Provides Clarification 40 Demonstrates Commitment 40 Stipulated Order 40 Diamyd Medical Diamyd 40 Completes Restructuring 40 Capacity Additions 40 Fanotech 40 Indefinite Delivery 40 Has Received 40 Restated Promissory Note 40 Receive Milestone Payment 40 Co. Ltd. 40 Tosoh Corporation 40 Treaties 40 Digital Rectal Massage 40 Elan Pharma 40 A5 Laboratories Inc. 40 CybeRelease OTC 40 Pilots Approve 40 Strikes Deal 40 Settle Patent Litigation 40 Amended MRA 40 Closes Private Placement 40 Tariff Order 40 Reduces Emissions 40 Successfully Completes Tender Offer 40 Secures Additional 40 Acquires Majority 40 Completes Buyout 40 Progresses 40 Previously Announced Acquisition 40 Zor Pharmaceuticals 40 Enters Into Agreements 40 Acacia Subsidiary 40 WPG Resources 40 Consent Order 40 Convertible Note 40 Enters Into Merger Agreement 40 Cost Reductions 40 Kwang Dong 40 Restructures 40 Oncolys 40 Commences Tender Offer 40 Completes Recapitalization 40 Panta Holdings 40 Norgine BV 40 Acquire Remaining Interest 40 Servicing Agreement 40 Successfully Tested 40 Seek Shareholder Approval 40 Receives Regulatory 40 binding Memorandum 40 Issues Clarification 40 Announces Underwriters Exercise 40 commercialize Aganocide compounds 40 Power Purchase Agreements 40 Delivers Next Generation 40 Safeguards Agreements 40 Announce Signing 40 Announces Non Brokered 40 Closes Second Tranche 40 Announce Definitive Merger 40 Unsecured Credit 40 MOSAID patents 40 IDGG 40 Announce Early Termination 40 NUEC 40 Supplemental Indentures 40 Restructures Debt 40 Terminate Merger Agreement 40 Emisphere Technologies Announces 40 Toreador Announces 40 Inter Governmental Agreement 40 Commences Consent Solicitation 40 OTCBB IGXT 40 Mines Gécamines 40 Milestone Payment From 40 Multi Lateral 40 Silicon Wafer 40 OTC SLUP 40 Amends Private Placement 40 Glassia 40 sublicensing agreements 40 Acquire Stake 40 Stocking Distributor 40 Announce Collaboration Agreement 40 Capital Invests 40 Receives Conditional 40 Significant Milestone 40 ALDA announces 40 Amends Revolving Credit 40 Renews Exclusive 40 Enters Option Agreement 40 evYsio Medical Devices 40 Expands Capabilities 40 Wafer Manufacturing 40 Files Patent 40 Product Lines 40 Abbotly 40 Implant Sciences Announces 40 Marketing Authorisation 40 Frankfurt XMPA 40 Receives ISO #:# [002] 40 Arrangement Agreement whereby 40 Achieves Prestigious 40 Announces Receipt 40 Introduces Revolutionary 40 Preferred Supplier 40 Submits Biologics License Application 40 Successfully Completed 40 Receives Certification 40 Contract Modifications 40 assignors 40 Unsecured Revolving Credit 40 Receives Shareholder Approval 40 Inc. OTCBB EBOF 40 Approve Merger 40 Its Previously Announced 40 Unsolicited Proposal From 40 Dalian Liyang 40 GenWay Biotech Inc. 40 Contract Valued 40 Mentor Protege Agreement 40 Share Repurchase Plan 40 Acquires 40 Reports Receipt 40 WTO TRIPS Agreement 40 Approves Merger 40 Presents Preclinical Data 40 SF Lease 40 Completes Initial 40 Enters 40 Proposed Combination 40 Announce Termination 40 Renegotiation 40 Mln 40 Modem Card 40 refusal ROFR 40 Commences Production 40 Receives Complete Response 40 Announces Stockholder Approval 40 Earns Milestone Payment 40 Activos Mineros